Search
for
Sort by
Research 241–270 of 1000+
- 皮膚組織の再生に向けた皮膚由来幹細胞に関する研究
- Androgenic disorders
- Cytostatics and immunosuppressive drugs
- Development of a Chitosan Nanofibrillar Scaffold for Skin Repair and Regeneration
- A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
- Influence of substance-P on cultured sebocytes
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Endocrinology & Metabolism News, August 2005
- Hair Growth After Gefitinib Treatment
- The Skin and Subcutaneous Tissues
- Generalised Glucocorticoid Resistance
- Iatrogenic androgen and estrogen excess in a postmenopausal woman presenting with facial erythema, acne, and hirsutism
- Asymptomatic hyperprolactinemia resulting from macroprolactemia
- Biochemical Testing of the Thyroid: TSH is the Best and, Oftentimes, Only Test Needed – A Review for Primary Care
- Dermatologic manifestations of endocrine disorders
- New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men
- Prevalence of hyperprolactinaemia in female premenopausal blood donors
- Testosterone Treatment in Women – An Overview
- A Meta-Analysis on the Relationship Between Hair Dye and the Incidence of Non-Hodgkin’s Lymphoma
- Hormones
- The Role of Hormonal Imbalances in Amenorrhea
- The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Physiologic skin changes in pregnancy
- Insulin Resistance and Skin Diseases
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Dermatology of androgen-related disorders
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- Ovarian Hypertension: Polycystic Ovary Syndrome